This protocol is judged by an institutional evaluate board, an independent team that reviews any medical trials involving human beings. If a review involves a Plan I drug, after the board approves the protocol as ethical, the scientists must make an application for an investigational new drug (IND) selection in the FDA.copyright to start with grew